NYSE:PAH - Platform Specialty Products Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $10.32 -0.16 (-1.53 %) (As of 03/22/2019 04:00 AM ET)Previous Close$10.48Today's Range$10.12 - $10.5552-Week Range$9.09 - $13.54Volume1.97 million shsAverage Volume2.45 million shsMarket Capitalization$2.98 billionP/E Ratio13.58Dividend YieldN/ABeta2.59 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Platform Specialty Products Corp. engages in the provision of technology chemical products and technical services. It operates its business through the Performance Solutions and Agricultural Solutions segments. The Performance Solutions segment formulates and markets chemistry solutions that are used in production, commercial packaging and printing, electronics, and oil and gas production and drilling. The Agricultural Solutions segment is based on a solutions-oriented business model that focuses on its product improvement address an ever increasing need for higher crop yield and quality. The company was founded by Martin E. Franklin on April 23, 2013 and is headquartered in West Palm Beach, FL. Receive PAH News and Ratings via Email Sign-up to receive the latest news and ratings for PAH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous chemical products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:PAH Previous Symbol CUSIPN/A CIK1590714 Webwww.platformspecialtyproducts.com Phone(561) 207-9600Debt Debt-to-Equity Ratio2.55 Current Ratio2.19 Quick Ratio2.00Price-To-Earnings Trailing P/E Ratio13.58 Forward P/E Ratio93.82 P/E Growth4.42 Sales & Book Value Annual Sales$3.78 billion Price / Sales0.79 Cash Flow$2.3724 per share Price / Cash Flow4.35 Book Value$9.96 per share Price / Book1.04Profitability EPS (Most Recent Fiscal Year)$0.76 Net Income$-296,200,000.00 Net Margins-14.14% Return on Equity8.48% Return on Assets2.23%Miscellaneous EmployeesN/A Outstanding Shares288,330,000Market Cap$2.98 billion Next Earnings DateN/A OptionableOptionable Platform Specialty Products (NYSE:PAH) Frequently Asked Questions What is Platform Specialty Products' stock symbol? Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH." How were Platform Specialty Products' earnings last quarter? Platform Specialty Products Corp (NYSE:PAH) posted its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.02. The specialty chemicals company had revenue of $1 billion for the quarter, compared to analyst estimates of $997.27 million. Platform Specialty Products had a negative net margin of 14.14% and a positive return on equity of 8.48%. The business's quarterly revenue was up 6.5% on a year-over-year basis. During the same period last year, the business posted $0.20 EPS. View Platform Specialty Products' Earnings History. What guidance has Platform Specialty Products issued on next quarter's earnings? Platform Specialty Products updated its FY 2019 earnings guidance on Monday, January, 28th. The company provided earnings per share guidance of $0.75-0.80 for the period, compared to the Thomson Reuters consensus estimate of $0.73. Platform Specialty Products also updated its FY 2018 guidance to EPS. What price target have analysts set for PAH? 6 Wall Street analysts have issued 12-month price targets for Platform Specialty Products' stock. Their forecasts range from $12.00 to $15.00. On average, they anticipate Platform Specialty Products' share price to reach $13.25 in the next twelve months. This suggests a possible upside of 28.4% from the stock's current price. View Analyst Price Targets for Platform Specialty Products. What is the consensus analysts' recommendation for Platform Specialty Products? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Platform Specialty Products. Has Platform Specialty Products been receiving favorable news coverage? Media coverage about PAH stock has been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Platform Specialty Products earned a daily sentiment score of 1.3 on InfoTrie's scale. They also gave press coverage about the specialty chemicals company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the next few days. Who are some of Platform Specialty Products' key competitors? Some companies that are related to Platform Specialty Products include Versum Materials (VSM), Element Solutions (ESI), Cabot (CBT), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience (PURE), HighCom Global Security (HCGS), GlyEco (GLYE), Artemis Therapeutics (ATMS) and Ener-Core (ENCR). What other stocks do shareholders of Platform Specialty Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Platform Specialty Products investors own include Micron Technology (MU), Alibaba Group (BABA), Two Harbors Investment (TWO), Uniti Group (UNIT), Fitbit (FIT), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), Intel (INTC), General Electric (GE) and Kratos Defense & Security Solutions (KTOS). Who are Platform Specialty Products' key executives? Platform Specialty Products' management team includes the folowing people: Rakesh Sachdev, Chief Executive Officer & DirectorBenjamin H. Gliklich, Executive Vice President-Operations & StrategyJohn P. Connolly, CFO & Principal Accounting OfficerJohn Edward Capps, Secretary, Executive VP & General CounselScot Robert Benson, President-Performance Solutions Who are Platform Specialty Products' major shareholders? Platform Specialty Products' stock is owned by a variety of of institutional and retail investors. Top institutional investors include FMR LLC (9.91%), BlackRock Inc. (5.74%), Dimensional Fund Advisors LP (5.50%), Gates Capital Management Inc. (2.33%), Vaughan Nelson Investment Management L.P. (1.41%) and Victory Capital Management Inc. (1.26%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products. Which major investors are selling Platform Specialty Products stock? PAH stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Wedge Capital Management L L P NC, First Manhattan Co., First Trust Advisors LP, Raymond James & Associates, Victory Capital Management Inc., Van ECK Associates Corp and ETF Managers Group LLC. Company insiders that have sold Platform Specialty Products company stock in the last year include Martin E Franklin and Pershing Square Capital Manage. View Insider Buying and Selling for Platform Specialty Products. Which major investors are buying Platform Specialty Products stock? PAH stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Consulta Ltd, Locust Wood Capital Advisers LLC, Vaughan Nelson Investment Management L.P., Gates Capital Management Inc., Royce & Associates LP, Hsbc Holdings PLC and BlackRock Inc.. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Insider Buying and Selling for Platform Specialty Products. How do I buy shares of Platform Specialty Products? Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Platform Specialty Products' stock price today? One share of PAH stock can currently be purchased for approximately $10.32. How big of a company is Platform Specialty Products? Platform Specialty Products has a market capitalization of $2.98 billion and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis. What is Platform Specialty Products' official website? The official website for Platform Specialty Products is http://www.platformspecialtyproducts.com. How can I contact Platform Specialty Products? Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at (561) 207-9600. MarketBeat Community Rating for Platform Specialty Products (NYSE PAH)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 178 (Vote Outperform)Underperform Votes: 262 (Vote Underperform)Total Votes: 440MarketBeat's community ratings are surveys of what our community members think about Platform Specialty Products and other stocks. Vote "Outperform" if you believe PAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: Trading Stocks - What are percentage gainers?